files/journal/2022-09-03_18-54-37-000000_456.png

Research Journal of Pharmacology

ISSN: Online 1993-6019
ISSN: Print 1815-9362
About US
Editors
Issues
Pages
Indexed in
127
Views
2
Downloads

Norstictic Acid Inhibits the Growth of Murine SV40 Transformed Lymphoid Carcinoma Cells In vitro

Bangolah I.E. Affeam, Shellaleh L.N. Alloula and Accomodo O.Q. Semeyannah
Page: 26-28 | Received 21 Sep 2022, Published online: 21 Sep 2022

Download Citation
https://doi.org/10.36478/rjpharm.2013.26.28

Full Text Reference XML File PDF File

Abstract

Researchers test the effects of Norstictic acid, secondary metabolite of the lichen Buellia zahlbruckneri, on the growth of murine SV40 transformed lymphoid carcinoma cells in vitro. Researchers find that Norstictic acid is a potent inhibitor of growth. Researchers, also find that Norstictic acid increases sensitivity of cells to radiation and this effect is significant at a radiation intensity lower than the standard intensity of cancer radiotherapy. On the basis of this study, Norstictic acid shows promise for combined-modality cancer treatment.

How to cite this article:

Bangolah I.E. Affeam, Shellaleh L.N. Alloula and Accomodo O.Q. Semeyannah. Norstictic Acid Inhibits the Growth of Murine SV40 Transformed Lymphoid Carcinoma Cells In vitro.
DOI: https://doi.org/10.36478/rjpharm.2013.26.28
URL: https://www.makhillpublications.co/view-article/1815-9362/rjpharm.2013.26.28